Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,460 public trials 1,142 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

NCT02326974

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Tennessee Oncology/Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

NCT03377387

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Baptist Alliance - McI Miami, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

NCT06840483

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (SKCCC) Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Siteman Cancer Center St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center - Main Campus New York, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

NCT04650581

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Southern Highlands Cancer Centre Bowral, New South Wales, Australia
  • Lake Macquarie Private Hospital Gateshead, New South Wales, Australia
  • Gosford Hospital Gosford, New South Wales, Australia
  • Macquarie University Hospital Macquarie University, New South Wales, Australia
View all 39 locations
View Trial Details
Active, Not Recruiting

Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer

NCT06702618

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • The First Affilliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Jiangmen Central Hospital Jiangmen, Guangdong, China
  • Xingtai People's Hospital Xingtai, Hebei, China
  • Harbin Medical University Cancer Hostipal Harbin, Heilongjiang, China
View all 13 locations
View Trial Details

Related conditions